What is Akerna Corp. (KERN)?

Akerna Corp. (KERN) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of KERN?

The current price of KERN is $0.31. Prices are updated in real time on Stocks360.

What is KERN's price-to-earnings (PE) ratio?

KERN's trailing twelve-month PE ratio is -0.36, based on current price and earnings per share data available on Stocks360.

What is KERN's market capitalization?

KERN's market capitalization is $162,320.00, placing it in the small-cap tier.

Akerna Corp. (KERN)

Stock analysis · NASDAQ · Healthcare · Medical - Healthcare Information Services

$0.31

Market Cap

$162.32K

PE (TTM)

-0.36

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.79

Day Range

$0.25 – $0.32

52-wk Range

$0.25 – $20.40

Avg Volume

N/A

Volume

1.22M

Akerna Corp. (KERN) is a publicly traded company in the Healthcare sector. Latest price: $0.31. Market cap $162.32K. Trailing PE -0.36. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 13, 2023

EPS $-0.32 vs est. $-0.43

Beat by $0.11

Proprietary Signals

Signal snapshot temporarily unavailable.

About Akerna Corp.

Akerna Corp., a Denver, Colorado-based company established in 2010, develops and provides sophisticated enterprise software solutions. These solutions primarily cater to businesses in the United States and Canada, enabling robust regulatory compliance and efficient inventory management. Their product portfolio includes MJ Platform, specifically designed for the burgeoning cannabis, hemp, and CBD industries, and Leaf Data Systems, a dedicated regulatory software for government agencies. A cornerstone of their offerings is a comprehensive "seed-to-sale" platform. This technology furnishes cultivators, processors, retailers, and clinics within the cannabis sector with essential tools for tracking, reporting, and maintaining compliance throughout the entire supply chain, extending to what they term 'seed-to-sale-to-self' data. Akerna further extends its expertise through consulting services for the cannabis industry, alongside offerings in business intelligence, data analytics, and other software-related support. Additionally, they offer Last Call Analytics, a distinct tool that assists alcohol brands in scrutinizing their retail sales performance.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.36×
P/S (TTM)	0.00×
P/B	0.03×
P/FCF (TTM)	-0.00×
EV / EBITDA	-6.15×
EV / Sales	0.97×
Earnings Yield	-588.96%
Free Cash Flow Yield	-88247.29%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$186.95M
Revenue (TTM)	$193.43M
Net Income (TTM)	-$956.00K
Free Cash Flow (TTM)	-$142.69M
Net Debt	$186.79M
Working Capital	-$110.93M
Gross Margin	52.48%
Operating Margin	-80.24%
Net Margin	-68.25%
Return on Equity	-20.25%
Return on Invested Capital	-12.43%